Skip to main content

Books in Pharmacology

Elsevier's Pharmacology collection studies how drugs interact with biological systems to improve health and treat disease. It covers pharmacodynamics, exploring drug effects on biology, and pharmacokinetics, studying how the body affects drugs. Branches like Pharmacogenetics. Essential for pharmacologists, this collection offers invaluable insights into drug interactions, efficacy, and safety, crucial for advancing drug development and improving patient outcomes.

    • Cardiovascular Pharmacology: Heart and circulation

      • 1st Edition
      • Volume 59
      • October 21, 2010
      • English
      • Hardback
        9 7 8 0 1 2 3 8 4 9 0 3 8
      • eBook
        9 7 8 0 1 2 3 8 4 9 0 4 5
      Cardiovascular disease remains a major cause of death and disability in developed countries and, increasingly so, in the developing world. Presented in this volume of Advances in Pharmacology are some of the most promising possibilities for treating large numbers of individuals afflicted with these conditions.
    • Meyler's Side Effects of Drugs in Cancer and Immunology

      • 1st Edition
      • April 19, 2010
      • Jeffrey K. Aronson
      • English
      • Hardback
        9 7 8 0 4 4 4 5 3 2 6 7 1
      • Paperback
        9 7 8 0 4 4 4 5 6 2 0 6 7
      • eBook
        9 7 8 0 0 8 0 9 3 2 8 8 0
      Elsevier now offers a series of derivative works based on the acclaimed Meyler’s Side Effect of Drugs, 15th Edition. These individual volumes are grouped by specialty to benefit the practicing biomedical researcher and/or clinician. There has been significant progress in the development of targeted therapy drugs that act specifically on certain cancers, and that minimize damage to normal cells. Oncologists and cancer researchers will rely on this volume to determine effective drug treatments.
    • Complex Enzymes in Microbial Natural Product Biosynthesis, Part A: Overview Articles and Peptides

      • 1st Edition
      • Volume 458
      • April 10, 2009
      • English
      • Hardback
        9 7 8 0 1 2 3 7 4 5 8 8 0
      • eBook
        9 7 8 0 0 8 0 9 2 3 3 5 2
      Microbial natural products have been an important traditional source of valuable antibiotics and other drugs but interest in them waned in the 1990s when big pharma decided that their discovery was no longer cost-effective and concentrated instead on synthetic chemistry as a source of novel compounds, often with disappointing results. Moreover understanding the biosynthesis of complex natural products was frustratingly difficult. With the development of molecular genetic methods to isolate and manipulate the complex microbial enzymes that make natural products, unexpected chemistry has been revealed and interest in the compounds has again flowered. This two-volume treatment of the subject will showcase the most important chemical classes of complex natural products: the peptides, made by the assembly of short chains of amino acid subunits, and the polyketides, assembled from the joining of small carboxylic acids such as acetate and malonate. In both classes, variation in sub-unit structure, number and chemical modification leads to an almost infinite variety of final structures, accounting for the huge importance of the compounds in nature and medicine.
    • Meyler's Side Effects of Endocrine and Metabolic Drugs

      • 1st Edition
      • January 20, 2009
      • Jeffrey K. Aronson
      • English
      Elsevier now offers a series of derivative works based on the acclaimed Meylers Side Effect of Drugs, 15th Edition. These individual volumes are grouped by specialty to benefit the practicing physician or health care clinician. Endocrine and metabolic diseases are common, includes diseases such as diabetes, thyroid disease, and obesity. Endocrinologists, including diabetes professionals, internal medicine and primary care practitioners, obstetricians and gynecologists, and others will find this book useful when treating endocrine or metabolic diseases.The material is drawn from the 15th edition of the internationally renowned encyclopedia, Meyler’s Side Effects of Drugs, and the latest volumes in the companion series, Side Effects of Drugs Annuals. Drug names have usually been designated by their recommended or proposed International Non-proprietary Names (rINN or pINN); when those are not available, clinical names have been used. In some cases, brand names have been used.This volume is critical for any health professional involved in the administration of endocrine and metabolics mediations.
    • Meyler's Side Effects of Analgesics and Anti-inflammatory Drugs

      • 1st Edition
      • December 16, 2009
      • Jeffrey K. Aronson
      • English
      • Paperback
        9 7 8 0 4 4 4 5 6 2 0 8 1
      • Hardback
        9 7 8 0 4 4 4 5 3 2 7 3 2
      • eBook
        9 7 8 0 0 8 0 9 3 2 9 4 1
      Elsevier now offers a series of derivative works based on the acclaimed Meyler’s Side Effect of Drugs, 15th Edition. These individual volumes are grouped by specialty to benefit the practicing biomedical researcher and/or clinician. Opioids and analgesics are members of a diverse group of drugs used to relieve pain. They are frequently used in combination with prescription and nonprescription pain relievers, and misuse is prevalent. Pain medicine specialists and physicians or surgeons will find this volume useful in prescribing the appropriate drugs for pain therapy and for preventing misuse of the medication.
    • Meyler's Side Effects of Antimicrobial Drugs

      • 1st Edition
      • November 25, 2009
      • Jeffrey K. Aronson
      • English
      • Hardback
        9 7 8 0 4 4 4 5 3 2 7 2 5
      • eBook
        9 7 8 0 0 8 0 9 3 2 9 3 4
      Elsevier now offers a series of derivative works based on the acclaimed Meyler’s Side Effect of Drugs, 15th Edition. These individual volumes are grouped by specialty to benefit the practicing biomedical researcher and/or clinician. This volume is essential for internal medicine physicians and general practitioners who prescribe antibiotic drugs, like penicillin and tetracycline that cure bacterial infections, and antiviral drugs used to treat patients with HIV and herpes viruses.
    • Chesley's Hypertensive Disorders in Pregnancy

      • 3rd Edition
      • April 16, 2009
      • James M. Roberts + 2 more
      • English
      • eBook
        9 7 8 0 0 8 0 9 2 1 1 8 1
      Hypertensive disorders remain one the major causes of maternal and fetal morbidity and death. It is also a leading cause of preterm birth now known to be a risk factor in remote cardiovascular disease. Despite this, the hypertensive disorders remain marginally studied, and their management is commonly controversial. Chesley’s Hypertensive Disorders in Pregnancy remains one of the beacons to guide this field, recognized for its uniqueness and utility. The Third Edition continues this tradition, focusing on prediction, prevention, and management for clinicians, and is an essential reference text for clinical and basic investigators alike. Differing from other texts devoted to preeclampsia, it covers the whole gamut of high blood pressure, not just preeclampsia.
    • Complex Enzymes in Microbial Natural Product Biosynthesis, Part B: Polyketides, Aminocoumarins and Carbohydrates

      • 1st Edition
      • Volume 459
      • April 11, 2009
      • English
      • Hardback
        9 7 8 0 1 2 3 7 4 5 9 1 0
      • eBook
        9 7 8 0 0 8 0 9 2 3 3 6 9
      Microbial natural products have been an important traditional source of valuable antibiotics and other drugs but interest in them waned in the 1990s when big pharma decided that their discovery was no longer cost-effective and concentrated instead on synthetic chemistry as a source of novel compounds, often with disappointing results. Moreover understanding the biosynthesis of complex natural products was frustratingly difficult. With the development of molecular genetic methods to isolate and manipulate the complex microbial enzymes that make natural products, unexpected chemistry has been revealed and interest in the compounds has again flowered. This two-volume treatment of the subject will showcase the most important chemical classes of complex natural products: the peptides, made by the assembly of short chains of amino acid subunits, and the polyketides, assembled from the joining of small carboxylic acids such as acetate and malonate. In both classes, variation in sub-unit structure, number and chemical modification leads to an almost infinite variety of final structures, accounting for the huge importance of the compounds in nature and medicine.
    • Side Effects of Drugs Annual

      • 1st Edition
      • Volume 31
      • November 25, 2009
      • Jeffrey K. Aronson
      • English
      • Hardback
        9 7 8 0 4 4 4 5 3 2 9 4 7
      • eBook
        9 7 8 0 0 8 0 9 3 2 9 9 6
      The Side Effects of Drugs Annual was first published in 1977. It has been continually published since then, as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs. Each new Annual continues to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of adverse drug reactions and interactions. An international team of specialists has contributed to the informative Annual by critically interpreting it and by pointing to whatever is misleading.
    • A Pharmacology Primer

      • 3rd Edition
      • February 7, 2009
      • Terry P. Kenakin
      • English
      • Paperback
        9 7 8 1 4 9 3 3 0 1 1 2 6
      • eBook
        9 7 8 0 0 8 0 9 2 3 3 3 8
      This successful guide assists scientists trained in molecular biology and related fields who now need to know the basic theories, principles and practical applications of pharmacology. This latest edition continues the tradition of better preparing researchers in the basics of pharmacology. With expanded hands-on exercises and the addition of Pharmacokinetics coverage, new human interest material including historical facts in pharmacology and a new section on therapeutics that will help readers identify with diseases and drug treatments.The ideal book for researchers in drug discovery who have seen their role shift from "individual" to "team player" where that team includes chemists, biologists, and others with strong, but varied, science backgrounds who must now work together toward their common pharmacology goal. At GlaxoSmithKline, a pharmaceuticals world-leader, Terry Kenakin regularly teaches a course for their research scientists and has drawn on his experience to create a pharmacology primer.